Pilot study on the use of guided imagery interventions prior to and during chemotherapy and immunotherapy in cancer patients and their effects on symptom burden

Pilot study on the use of guided imagery interventions prior to and during chemotherapy and immunotherapy in cancer patients and their effects on symptom burden - ONCOMAGINE

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00038380

Enrollment

112

Registered

2026-01-22

Start date

2026-02-19

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients receiving immune therapy or chemotherapy

Interventions

Group 1: Intervention Group: Oncological patients complete a questionnaire assessing demographic characteristics, symptom burden, psychosocial distress, and health-related quality of life. Participant

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Oncological patients - German language comprehension - Written informed consent provided by the participant after receiving study information - Access to the internet - participant owns a mobile device (smartphone/tablet)

Exclusion criteria

Exclusion criteria: - Concurrent participation in other supportive intervention studies - Lack of informed consent from the patient - Insufficient language comprehension - Hearing impairments - No access to a mobile device

Design outcomes

Primary

Measure	Time frame
Psychosocial Distress (NCCN Distress Thermometer, HADS-D) Oncological patients complete questionnaires on psychosocial distress, symptom burden, and health-related quality of life at the start of study participation. Participants document their symptom burden before and after each guided imagery in an intervention diary. After six weeks, a final assessment is conducted, supplemented by questions addressing the acceptability and feasibility of the imagery-based interventions.	—

Measure

Time frame

Psychosocial Distress (NCCN Distress Thermometer, HADS-D) Oncological patients complete questionnaires on psychosocial distress, symptom burden, and health-related quality of life at the start of study participation. Participants document their symptom burden before and after each guided imagery in an intervention diary. After six weeks, a final assessment is conducted, supplemented by questions addressing the acceptability and feasibility of the imagery-based interventions.

—

Secondary

Measure	Time frame
Symptom burden (PRO-CTCAE) Health-related quality of life (excerpt from the QLQ-C30 questionnaire)	—

Countries

Germany

Contacts

Public ContactBeke Seefried

Institut für medizinische Psychologie und Soziologie

beke.seefried@uksh.de+4943150030832

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026